From: MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy
Cancers | Targeted gene products†| References |
---|---|---|
Cancers with down-regulation of miR-203a-3p | ||
 | Acting as oncogenes or tumor promoters | |
CRC | TYMS | Li et al. (2015a) |
Glioblastoma | TYMS | Chen et al. (2017b) |
NSCLC | AVL9, BIRC5, DLX5, E2F1, ZEB2 | Liang et al. (2020); Yang et al. (2020); Wang et al. (2020a) |
BLCA | SIX4 | Na et al. (2019) |
PDAC | SNAI2 | An and Zheng (2020 |
 | Acting both as oncogenes and tumor suppressors, or unclassified | |
CRC | THBS2 | Qian et al. (2019) |
GC | IGF1R | Wang et al. (2018a) |
OVCA | ATM | Liu et al. (2019a) |
Cancers with up-regulation of miR-203a-3p | ||
 | Acting as tumor suppressors | |
HCC | IL24, PTEN | |
 | Acting both as oncogenes and tumor suppressors, or unclassified | |
CRC | PDE4D | Chen et al. (2018) |